DFFA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.127200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.219600E-01
Normal-vs-Stage2
8.759400E-01
Normal-vs-Stage3
4.554600E-01
Normal-vs-Stage4
1.649450E-01
Stage1-vs-Stage2
8.835600E-01
Stage1-vs-Stage3
2.923000E-01
Stage1-vs-Stage4
1.574180E-01
Stage2-vs-Stage3
3.674600E-01
Stage2-vs-Stage4
9.278400E-03
Stage3-vs-Stage4
6.690300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.222000E-01
Normal-vs-AfricanAmerican
7.231600E-01
Normal-vs-Asian
9.667800E-01
Caucasian-vs-AfricanAmerican
7.402600E-01
Caucasian-vs-Asian
9.270800E-01
AfricanAmerican-vs-Asian
7.514600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.510000E-01
Normal-vs-Female
7.763600E-01
Male-vs-Female
1.579560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.008200E-01
Normal-vs-Age(41-60Yrs)
5.750400E-01
Normal-vs-Age(61-80Yrs)
8.639800E-01
Normal-vs-Age(81-100Yrs)
9.122800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.451200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.708200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.996400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.458600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.841400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.789000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.234000E-01
Normal-vs-Daily Drinker
9.053600E-01
Normal-vs-Weekly Drinker
9.096400E-01
Normal-vs-Occasional Drinker
4.496800E-01
Normal-vs-Social Drinker
6.947000E-01
Non Drinker-vs-Daily Drinker
9.406600E-01
Non Drinker-vs-Weekly Drinker
7.301600E-01
Non Drinker-vs-Occasional Drinker
1.642610E-01
Non Drinker-vs-Social Drinker
4.322400E-01
Daily Drinker-vs-Weekly Drinker
6.791200E-01
Daily Drinker-vs-Occasional Drinker
7.709900E-02
Daily Drinker-vs-Social Drinker
3.200000E-01
Weekly Drinker-vs-Occasional Drinker
2.605000E-01
Weekly Drinker-vs-Social Drinker
6.200600E-01
Occasional Drinker-vs-Social Drinker
5.544000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.579400E-01
Normal-vs-Grade 2
9.814000E-01
Normal-vs-Grade 3
9.356200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.177300E-03
Grade 1-vs-Grade 3
3.315500E-03
Grade 1-vs-Grade 4
8.579400E-01
Grade 2-vs-Grade 3
4.483200E-01
Grade 2-vs-Grade 4
9.814000E-01
Grade 3-vs-Grade 4
9.356200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.380800E-01
Normal-vs-NonDiabetic
9.641800E-01
Diabetic-vs-NonDiabetic
9.003800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.494000E-01
Normal-vs-NoPancreatitis
9.598200E-01
Pancreatitis-vs-NoPancreatitis
3.025800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.661000E-01
Normal-vs-N1
8.796400E-01
N0-vs-N1
5.010600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.029000E-01
Normal-vs-TP53-NonMutant
7.618800E-01
TP53-Mutant-vs-TP53-NonMutant
1.365180E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
